On the 10th of March, Swiss television interviewed Dr. Markus Rimann on animal experiments, research, and alternatives. The questions were: how far are we in bioprinting? Can animal experiments be replaced? If so, which ones? How vital could bioprinting be in the future? What are the hopes in this?

Readily3D develops a new generation of bioprinters that print objects directly as a volume as opposed to layer-by-layer. Our contactless tomographic illumination technology shapes sensitive cells and biomaterials into biological systems without impairing their viability. Volumetric printing preserves cells and makes research more efficient by simplifying design iterations and statistical studies.

During this TEDD Annual Meeting 2021, we would like to show MPS application diversity across different industries, which is in line with the National Thematic Network Innovation Booster project vision, Cell Insights 4 Life" (NTN IB CI4L).

The Swiss-wide consortium, including TEDD and the Thematic Platform In Vitro Diagnostics (TP-IVD), aims to foster the development of next-generation microphysiological systems (MPS) based on 3D cell culture, organoid, and organ-on-chip technology.

You will receive an update on the progress of the project NTN IB CI4L. This network will provide a fruitful environment to enable radical innovations by covering multidisciplinary fields and connecting different industry sectors, like pharma, medtech, biotech, cosmetics, diagnostics, fragrances, and food with each other.